Bank of Jackson Hole Trust’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-15,439
Closed -$434K 343
2026
Q1
$434K Buy
15,439
+622
+4% +$16.6K 0.21% 99
2025
Q4
$369K Buy
14,817
+950
+7% +$24K 0.18% 101
2025
Q3
$353K Buy
13,867
+2,051
+17% +$50.6K 0.18% 104
2025
Q2
$286K Buy
11,816
+1,854
+19% +$43.2K 0.16% 117
2025
Q1
$263K Sell
9,962
-2
-0% -$52 0.17% 114
2024
Q4
$264K Buy
+9,964
New +$270K 0.18% 101

Other funds holding PFE

Bank of Jackson Hole Trust's PFE Position: Q2 2026 in Review

Bank of Jackson Hole Trust sold out of Pfizer (PFE) in Q2 2026, closing a stake of 15,439 shares — an estimated $434K sold.

Bank of Jackson Hole Trust first reported a position in PFE in Q4 2024 and held it in 6 quarters. The position peaked at $434K in Q1 2026. 2,820 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Bank of Jackson Hole Trust reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
  • Bank of Jackson Hole Trust sold 15,439 Pfizer shares in Q2 2026, an estimated $434K.
  • Bank of Jackson Hole Trust first reported a position in Pfizer in Q4 2024 and held it in 6 quarters.
  • Bank of Jackson Hole Trust's Pfizer position peaked at $434K in Q1 2026.
  • 2,820 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Bank of Jackson Hole Trust's 13F filing for Q2 2026.